Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RuiLian Financial Group Company Limited is a financial services and investment holding company, a subsidiary of Chuanglian Holdings Limited. It is licensed for securities dealing, advising, and asset management activities, managing approximately HK$2.0 billion in assets. The company is involved in securities trading, asset management, advisory services, and cryptocurrency investments, with a geographic focus on PRC and Hong Kong.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ruilian Investment.